<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 296 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page295.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=296">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 296 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 296</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=296"><img src="../thumb/296.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Anti-Microbials - 18.11                                                        2020-04 / 259
       Drug interactions: Incr.risk of convuls.with concurr.quinine, poss.po-  (S2) Prophylax. (S4) Treatm.  Side effects: Hypoprothrombinaem., blackwater fev./ asthma pre-
       tent.fatal QTC interv. prolongat.with halofantrine, ß-adrenerg.block.,   Indications: Malaria prophylax.where chloroquine reisist not en-  cipit., tinnit., imp.hear., headache, GI/ vis. disturbs., vertigo, skin
       Ca chann.block., quinidine & quinine, plasma lev.of valproic acid.re-  count., malaria treatm. provid.malaria was not contract.in a chloro-  reacts., fev., dyspn., angioed., bld.dyscras., hypoglycaem., ren.fail.,
       duc., poss.attentuat.of immunisat. induc.by oral typhoid vaccines.  quine resist.area or chloroquine prophylax.tak., adjuvant managem.  tetanus, pain/loc.reacts.with IM admin.
       METRONIDAZOLE B BRAUN,        rheum.arthrit., discoid & SLE.  Warnings and special precautions: Sev.somet. fatal cardiotoxic.
                                     TABS, [P/S] A147.
                                                                  from rapid infus., avoid in myasth. grav., atrial fibrillat./card.conduct.
       B Braun Medical [P/S]         747297-029: 200 mg, 14, R68,34  defects/heart block/ any ser.card.dis., poss.cause haemolys.in some
       Metronidazole.                747297-010: 200 mg, 100, R487,81  types of G6PD defic., monit.bld gluc.conc., poss. foet.abnormal., use in
       Indications: Anaerob.infects.treatm.in post op wound infects./pelv.  Dosage: Malaria prevent: Adults & childr. over 12 yrs: 2 tabs.  pregn.if unavoid., abort./ congenit.malformat.with large dos., safety
       inflamm.dis., post-op prophylax. of anaerob.infects.in appendicect.,   as sngl.dos.wkly. Infts.& childr.up to 12 yrs: 5 mg/kg bm wkly. Start   & effic. not est.with IM admin.
       gynae.& colon surg.           1-2 wks.bef.enter.& cont.for 4-6 wks.aft.leaving area. Taken on same   Drug interactions: Agents with neuromusc.block. activ. eff.potent.,
       (S4) IV INFUS, 41/20.2/0155. 500 mg/100 ml  day each week with food.  tot.body clear.of digox.reduc., anticoag. eff.enhanc., reduc.clear.&
       710435-001: 1x100 ml bott., R10,92  Malaria treatm: Adults & childr.over 12 yrs: 4 tabs.immed., 2 tabs.  elimin.half-life prolong. with cimetidine, poss.antagonist.with chlo-
       Dosage: Anaerob.infects.treatm: Adults & adolesc. over 12   aft.6-8 hrs, then 2 tabs. dly.for next 2 days. Adjust.treatm.to sev.of   roquine, incr.ventr.dysrhythm.risk with halofantrine/ amiodarone/
       yrs: 100 ml IV infus.8 hrly. Inj. should be infus. at rate of 5 ml/min.   infect., condit., age & weight of pt.  terfenadine/cisapride/ pimozide, incr.convuls.risk with mefloquine.
       May be admin. concur.with other bacteriolog.appropr. antibact.agents   Infts.& childr.up to 12 yrs: 10 mg/kg bm follow. by 5 mg/kg
       but must be admin.separat. Substit.oral med.as soon as feasible at   bm.aft.6-8 hrs.& then 5 mg/kg bm dly.x2 days.   TRICHAZOLE INFUS, Fresenius Kabi [P/S]
       400 mg 3xdly. Contin.treatm.for 7 days depend.on clinic./ bacteriol.  Rheum.arthr: 1 tab/day.   Metronidazole.
       assessm. Childr.und.12 yrs: As for adults but sngl.IV dos.bas.on   Discoid & system.lupus erythemat: 1 -2 tab dly., reduc.grad.  Indications: Anaerob.infects.in post-op wound infects. & pelv.in-
       (1,5 ml) 7,5 mg/kg bm & oral dos.of 7,5 mg/kg bm.  once sympts.controll.  flamm.dis., post-op prophylax. of anaerob. infects. admin.bef./aft.
       Prevent: Adults & adolesc.over 12 yrs: 100 ml by IV infus.im-  Contraindications: Retin./vis.field chang., pregn.  appendicect./ gynae. & colon surg.
       med.bef./dur./aft.op.foll.by same dos. 8 hrly unt.oral meds.can be   Side effects: Retinal damage (prolong.use), precipitat./exacer-  (S4) INFUS. Q/20.2/92. 500 mg/100 ml.
       giv. Childr.und. 12 yrs: As for adults but sngl.IV dos.bas.on (1,5 ml)   bat.myasthen.gravis/myasthen. gravis-like syndr., skin disords.incl.  772232-091, 1x100 ml, R9,83
       7,5 mg/kg bm & oral dos.of 7,5 mg/kg bm.  erupt., prurit., urticar., erthema multiforme, Stev.-Johns.syndr., toxic.   718918-001: 500 mg/100 ml, 1X100 ml, R12,66
       Contraindications: Safety in pregn. & lactat. not est., other imi-  epiderm.necrolys., exfoliat.dermatit.& simil. desquamat.-type events,   Dosage: Treatm: Adults & childr.over 12 yrs: 100 ml (500 mg)
       dazoles.                      hair loss, blue-black skin & mucous membr.pigmentat., exacerbat.of   IV 8 hrly.infus.at rate of 5 ml/min. May be admin.alone or concurr.
       Side effects: Pseudomembr.colit., skin reacts. incl.pustul.erupt., fev.,   psorias., bleach.of hair pigment, photosens., anaphylactic/toid reacts.  (but separat.) with other appropr.antibiot.agents. 7 day treatm.is
       angioed., flush., anaphylax., serum sickn.-like sympt., GI disturbs. incl.  incl.angioed., seiz., polyneurit., neuropathy, headache, myopathy,   gen.satisfact.
       taste disords., headache, furred tong., stomatit., antibiot.assoc.colit.,   psych. disords., vis.disturb., revers.corneal opacities, card.disords.,   Childr.und.12 yrs: As for adults but sngl.IV dos. bas.on 1,5 ml
       weakn., dizzin., periph. neuropathy/seiz.esp.at high dos./prolong. use,   bld.dyscras., tinnit., reduc. hear., nerve deafn., GI disturbs., abnorm.  (7,5 mg)/kg bm & oral dos.of 7 mg/kg bm.
       atax., drowsin., insomn., mood/ment.state chang., bld.dyscras., ar-  liv.funct. tests, hepatit.  Prophylax: Adults & childr.over 12 yrs: 100 ml (500 mg) by IV in-
       thralg., myalg., trans.vis. disords., revers.pancreatit., urethr.discomf.,   Special precautions: Reg.ophthal.exam.with prolong.admin., re-  fus.immed.bef./dur.or aft.surg.foll.by same dos.8 hrly unt.oral meds.
       dark.urine, cholest.hepatit.  port.resist.to Plasmodium Falciparum., report flu-like sympts.appear   can be giv. Childr.und.12 yrs: As for adults but sngl. IV dos.bas.on
       Special precautions: Combin.ther.indic.for mix.infects., poss.  in pts. been to malar.area, imp.liv./ren.funct., porphyr., psorias., epilep.  1,5 ml (7,5 mg)/kg bm & oral dos.of 7 mg/kg bm.
       ac.psych.in alcohol.pts.with concom.disulfiram., av.alcoh.dur.& for   hist., underly.hist.of myasthen. grav., admin.at least 2 hrs.apart from   Contraindications: Bld.dyscras., CNS dis., pregn. & lactat.
       at least one day aft.ther., poss.Li toxic., monit.treatm.if admin.more   antacids/ koalin, use in pregn only when unavoid.if risk more hazard.  Side effects: Hypersens.reacts.incl.angioed./ anaphylax., anorex.,
       than 10 days for signs of periph. neuropathy, discont.if neurologic.S/E   than potent.damage of foet., G6PD defic. pts.observ.for haemolyt.  vertigo, insomn., drowsin., psychot. disords.incl.confus./irritab./hal-
       noted, sev.liv.impairm., bld.dyscras., chron./act.CNS & periph.nerv.  anaem., mosquito bite prevent.mainstay of malar.prophylax., not to   lucinat./ mood changes & depress., periph.neuropathy, weakn., diz-
       syst.dis., poss.mask immunolog. respons.in untreat.early syphil.  be admin.with halofantrine.  zin., encephalopathy, subac.cerebell. syndr., trans.diplop.& myop.,
       Drug interactions: Poss.disulfiram-like react. with alcoh., imp.me-  Drug Interactions: Antacids/kaolin can reduc. decr.clear.with cime-  leucopen., bld. dyscras., thrombophlebit., nas.congest., coat.tong.,
       tab./excret.of warfar./ phenytoin /Li/fluorouracil, phenytoin poss.  tidine, OT interv.prolong.with halofantrine, mefloquine low.convuls.  glossit., dry mouth, unpleas.taste, GI disturbs., pancreatit., rais.
       incr. metronidazole metab., poss.reduc.effic.with phenobarb., poss.  threshold, activ.of antiepilept.meds.poss impair., ciclospor. plasma lev.  liv.enzym., revers.abnorm.LFT, cholestat. hepatit., skin reacts.incl.
       incr.plasma conc.with cimetidine, poss.incr.cyclosporin ser.lev.risk,   incr., antibody respons.to human diploid rabies vaccine poss.affect.  erythem.erupt., prurit., fleet.joint pains resembl.ser.sickn., arthralg.,
       poss.incr.Li conc.            PLASMOQUINE, Medchem [P/S]   myalg., urethr.changes
                                                                  Warnings and special precautions: Monit. treatm. if admin. long.
       MIRQUIN, (Cipla Medpro) Mirren [P/S]  Chloroquine sulph.monohydr.equiv.to chloroquine base.  than 10 days, sev.liv.dis., periph. neuropathy/trans epileptiform seiz
       Chloroquine sulph.68 mg equiv.to 50 mg chloroquine base/5 ml  (S1) Prophylax. (S4) Treatm.  & leucopen. report.with prolong./intens.ther., pseudomembr. colit.
       Indications: Malaria prophylax.where chloroquine resist.not en-  Indications: Suppress.& treatm.of malaria caus. by plasmodium   report., long.half-life in neonates, sev.ren.impairm., concom.alcoh.&
       count., malaria treatm. provid.malar.was not contract.in a chloroquine   vivax, sens.strains of plasmodium falciparum & gametocytes of P   disulfiram poss.incr.S/E, concom.busulfan, hepat. encephalopathy, im-
       resist.area or chloroquine prophylax.taken.  vivax., rheumat. arthrit., discoid lupus erythematos.  munolog.respons.in untreat. early syphil. poss.mask., urine darken.,
       (S4) PROPHYLAX. & (S4) TREATMENT.  CAPS. Z/20.2.6/127.     mutagen. in bact. & carcinogen.in some anim., monit.INR with con-
       SYRUP, Z/20.2.6/388.          794333-001: 146,7 mg, 20, R55,60  com. warfar., substit.with oral ther.as soon as feasible.
       878790-004: 100 ml, R37,63    794333-028: 146,7 mg, 100, R278,00  Drug interactions: Signific.incr.in busulfan plasma lev., ac.psychos./
       Dosage: Inft.& childr.oral dos.should not exceed 10 mg/kg bm/day.  794333-036: 146,7 mg, 500, R1 390,00  confus.with disulfiram, disulfiram react.with alcoh., anticoag.eff.
       Prophylax: Admin.wkly.commenc. 2wks-24 hrs. bef. enter.area &   Dosage: Malaria prophylax: Adults & childr. over 12 yrs: 2   of oral anticoags. potent., Li lev.incr., poss.elev.of ciclospor. ser.lev.,
       cont.for 4-6 wks.aft leav. Childr: Recomm.dos: 5 mg/kg/wk.  caps/wk. Childr. 6-12 yrs: Calc. dos. accord. to bm. Recom.paed.  phenyt.acceler.metabol., plasma conc. decr.by phenobarbit., 5-flou-
       Treatm: Childr: Usual total oral dos: 25 mg/kg bm admin over 3 days.   dos. 5 mg base/ kg bm/wk. Gen.guide: 1 cap/wk. Beg.1-2 wks. bef.   rouracil clear. reduc., elimin.delay.with cimetid.
       Eg. 10 mg/kg, follow.aft.6-8 hrs. by 5 mg/kg, then 5 mg/kg xnext 2   enter.malarial area & contin.for 4-6 wks.aft. expos.
       days OR 10 mg/kg dly.x2 days, then 5 mg/kg on 3 rd  day.  Malaria treatm: Adults & childr.over 12 yrs: 4 caps.as sngl.dos.  TRICHAZOLE, (Aspen Pharmacare: Pharma) Pharmacare [P/S]
       Side effects: Headache, GI disturbs., prurit., skin erupts., ment.  follow.by 2 caps 6 hrs.later & then 2 caps. dly x2 days. Childr. 6-12   Metronidazole.
       chang., vis.disturbs.with high dos.& prolong. use, otic.dysfunct., bld.  yrs: Recom. paed. dos: 10 mg base/kg bm, foll.by 5 mg/kg bm.aft.6   Indications: Urogen.trichomon., giardias., ac. Vincent’s dis., amoe-
       dyscras., hair loss, hair pigment.bleach., blue-black pigmentat.of   hrs. then 5 mg/kg dly x2 days. Gen.guide: 2 caps as sngl.dos.follow.  bias., anaerob.infects.
       mucous membr.& skin, photosens., tinnit., reduc. hear., nerve deafn.,   by 1 cap 6 hrs.later & then 1 cap dly x2 days.  (S4) TABS. M/20.2.6/194, 195.
       myopathy, neuromyopathy.      Discoid lupus erythematos: 150 mg dly.reduc. grad.once   772216-010: 200 mg, 250, R52,98
       Special precautions: Imp.liv./ren.funct., porphyr., psoriasis, epilep.  sympts.controll.  772224-013: 400 mg, 100, R53,61
       hist., observ.G6PD pts. for haemolyt anaem.  Rheumat.arthrit: 150 mg dly. Max.dos: 4 mg/kg  Dosage: Admin.with/aft.food
       Drug interactions: Antacids can reduc.absorpt., cimetidine impairs   Side effects: Headache, GI disturbs., prurit., skin erupt., psychot.  Trichomon: Adults & childr.over 10 yrs: Sngl. dos.of 2 g.or 200-
                                                                                           nd
       chloroquine serum clear.      episod., anx.& personal.chang., vis. disturbs.with prolong.treatm.at   250 mg 3xdly x7 days or 400 mg 2xdly x7 days. Admin.2  course
                                                                  aft.4-6 wks.if no respons. Concom.treatm.of sex.partn. Childr: 7-10
                                     high dos., hypotens. & ECG chang., bld.disords., loss of hair, bleach.
       MOZITEC, (Activo) Glenmark [P/S]  of hair pigment, blue-black pigmentat.of mucous  membr., skin pho-  yrs: 100 mg 3xdlyx7 days. 3-7 yrs: 100 mg 2xdly.x7 days. 1-3 yrs:
       Atovaquone 250 mg, proguanil HCl 100 mg.  tosens., neurit., reduc. hear., nerve deafn., neuromyopathy, myopathy.  50 mg 3xdly.x7 days
       Indications: Prophylax.of drug sens. & drug resist.P.Falciparum   Special precautions: Reg.ophthalm.examinat. with long-term large   Ac/chron.hepat. or intestin.amoebias: Adults & childr.over 10
       malaria in conjunct. with offic. guidelin. & loc.info.on preval.of an-  dos.ther., use in pregn.only if malaria risk is more hazard.than potent.  yrs: 2-2,4 g as sngl.dos.x2-3 consec.days. Alternat.400-800 mg 3xdly
       timalar.drug resist.          damage to foetus, if taken dur.pregn.dly.folic acid supplem. advis.,   x5-10 days. Childr: 7-10 yrs: 200-400 mg 3xdly x5-10 days. 3-7 yrs:
       (S2) TABS, 47/20.2.6/1014     imp.liv./ren.funct., porphyr., psorias., G6PD defic.  100-250 mg 3xdly x5-10 days. 1-3 yrs: 100-200 mg 3xdly x5-10 days.
       720917-001: 12, R310,46                                    Giardias: Adults & childr.over 10 yrs: 2 g as sngl.dos.x3 success.
       Dosage: Must be taken with food/milk at the same time dly. Rep.dos.  QUININE DIHYDROCHLORIDE FRESENIUS 300 mg/1 ml,   days or 250 mg 3xdly x5-7 days. Childr. 7-10 yrs: 1 g as sngl.dos.
       if vomit.occurs within 1 hr.of dos. Prophylax: Commenc.1-2 days bef.   Fresenius Kabi [P/S]  x3 success. days. 3-7 yrs: 600 mg as sngl.dos.x3 success.days. 1-3
       enter.malar.area and cont.dly. x7 days aft.leav. area.  Quinine dihydrochlor.  yrs: 400 mg as sngl.dos.x3 success.days
       Adults: 1 tab.dly.            Indications: Sev.forms of chloroquine-resist. falciparum ma-  Vincent’s dis: Adults: 200 mg 3xdly x3 days or 400 mg 2xdly x3 days.
       Contraindications: Sev.ren.impairm., safety in pregn. & lactat.  laria treatm.  Anaerob.bact.infects: Adults: Init.800 mg then 400 mg 8 hrly x7
       not est., no studies in sev.hepat. impairm., safety & effic.in pts.  (S4) INJ, 31/12/0261. 300 mg/ml  days. Childr: 7,5 mg/kg bm 8 hrly. x7 days.
       weigh.&lt; 40 kg not est.        867926-007: 10x 1 ml, R268,72  Contraindications: Bld.dyscras., act.CNS dis., pregn.& lactat.
       Side effects: Bld.dyscras., angioed., hyponatraem., GI disturbs., oral   Dosage: Sev./complic.falciparum malar: Admin. by slow IV infus.   Side effects: GI disturbs., metal.taste, dry mouth, furr.tong., glos-
       ulcerat., stomatit., elev. liv.enzym., anorex., CNS effs., headache, fev.,   usual.for 7 days & monit. cardiotoxic. Chang.to oral admin.as soon   sit., stomatit., headache, pseudomembran. colit., periph.neuropathy,
       cough, hair loss, rash.       as poss. complet.the course.  epileptiform seiz.with high dos./prolong ther., CNS eff.incl.mood
       Warnings and special precautions: Treat with diff. bld. schizon-  Init.load.dos: 7 mg/kg bm giv.over 30 mins.foll. immed.by maint.  changes/depress.or confus., flush., dysur., urticar., angio neurot.
       ticide if recrudesc.infects.due to P.falciparum occur/chemoprophylax.  infus.or an init.dos.of 20 mg/kg up to max.1,4 g giv.over 4 hrs.with   oed., leucopen., skin rash., prurit., urethr.discomf., urine darken.,
       fails, contin. with norm.dos.if diarrh.occurs, contin.with person. pro-  maint.infus.start. 8 hrs later.  anaphylax., rais.liv.enzym.
       tect.meas.if diarrh.& vomit.occurs, maint.norm. prevent.meas.when   Maint.infus: 10 mg/kg giv.8 hrly over 4 hrs. Dos. reduc. by one third   Warnings and special precautions: Avoid alcoh.as disulfiram-
       visit.areas know/susp.to be malar.infect., concom.rifampicin/rifabutin   or one half if parent.ther.reqd. for more than 48 hrs. May be giv.IM   like react.poss., monit.& discont. if periph. neuropathy or CNS toxic.
       not recomm., concom.indinavir.  if IV infus.not poss. with a load.dos.of 20 mg/kg foll.by maint. dos.   devel., sev. liv.damage, ren.fail.
       Drug interactions: Tetracycl./metoclopramide/ rifampicin & rib-  of 10 mg/kg 8 hrly.  Interactions: Warfar.eff.enhanc., phenobarbit. reduc.half-life to
       abutin decr. atovaquone plasma conc., trough lev.of indinavir decr.  Combin.with pyrimethamine & a sulfonamide or with a tetracycl.  approx.3 hrs.
                                     may be used.
       NIVAQUINE, Zentiva [P/S]      Contraindications: Tinnit., opt.neurit., in pres.of haemolys., black-  WELLVONE, Litha [P/S]
       Chloroquine sulph.equiv.to chloroquine base.  water fev.attack.  Atovaquone</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page295.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page291.html">291</a>&nbsp;&nbsp;&nbsp;<a href="page292.html">292</a>&nbsp;&nbsp;&nbsp;<a href="page293.html">293</a>&nbsp;&nbsp;&nbsp;<a href="page294.html">294</a>&nbsp;&nbsp;&nbsp;<a href="page295.html">295</a>&nbsp;&nbsp;&nbsp;<a href="page296.html">296</a>&nbsp;&nbsp;&nbsp;<a href="page297.html">297</a>&nbsp;&nbsp;&nbsp;<a href="page298.html">298</a>&nbsp;&nbsp;&nbsp;<a href="page299.html">299</a>&nbsp;&nbsp;&nbsp;<a href="page300.html">300</a>&nbsp;&nbsp;&nbsp;<a href="page301.html">301</a>
             </td>
             <td width="35%"><a href="page297.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page297.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
